Admedus Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
7,403.00
7,900.10
10,133.50
14,150.50
22,324.10
25,601.10
Cost of Goods Sold (COGS) incl. D&A
7,613.60
13,645.30
21,085.00
25,643.70
28,294.80
38,087.20
Gross Income
210.60
5,745.20
10,951.50
11,493.20
5,970.70
12,486.10
SG&A Expense
3,495.30
6,223.30
13,924.30
13,737.20
7,281.10
10,777.60
EBIT
-
13,760.10
25,062.90
25,230.40
13,251.80
23,263.70
Unusual Expense
2,561.50
1,700.00
-
-
-
584.10
Non Operating Income/Expense
10.30
1,921.50
75.80
4,607.90
2,832.10
347.90
Pretax Income
1,861.80
10,098.00
24,896.10
29,672.50
15,923.60
24,698.70
Income Tax
604.80
1,890.30
1,903.80
4,542.10
3,247.40
-
Equity in Affiliates
1,161.50
-
-
-
-
-
Consolidated Net Income
2,418.50
8,207.70
26,800.00
25,130.40
12,676.20
24,698.70
Net Income
1,892.40
6,616.50
25,253.80
24,013.90
12,312.10
24,217.20
Net Income After Extraordinaries
1,892.40
6,616.50
25,253.80
24,013.90
12,312.10
24,217.20
Net Income Available to Common
1,892.40
6,616.50
25,253.80
24,013.90
12,312.10
24,217.20
EPS (Basic)
0.02
0.05
0.16
0.13
0.05
0.08
Basic Shares Outstanding
98,305.40
121,718.10
153,281.10
190,841.10
251,382.30
305,513.40
EPS (Diluted)
0.02
0.05
0.16
0.13
0.05
0.08
Diluted Shares Outstanding
98,305.40
121,718.10
153,281.10
190,841.10
251,382.30
305,513.40
EBITDA
4,173.10
12,297.00
23,045.90
23,249.00
11,394.90
21,853
Other Operating Expense
739.90
1,791.50
187.00
-
-
-
Non-Operating Interest Income
12.20
40.50
91.00
165.80
160.30
41.80
Minority Interest Expense
526.10
1,591.20
1,546.10
1,116.50
364.10
481.50

About Admedus

View Profile
Address
9 Sherwood Road
Toowong Queensland (QLD) 4066
Australia
Employees -
Website http://www.admedus.com
Updated 07/08/2019
Admedus Ltd. engages in the development, commercialization, and distribution of medical products and technologies. It operates through the following segments: Disposable Medical Products and Medical Services Distribution, Bio Implant Operations, Regenerative Medicine Research and Development (R&D), Immunotherapies R&D. The comapny also offers tissue engineering, CardioCel, and other medical products.